Zhejiang Supor Pharmaceuticals is an API manufacturer based in China. It holds 20 active US drug master files across a filed portfolio of 19 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3005183062 |
| Molecule | Regulators | Docs |
|---|---|---|
| Bupropion | US FDA | 2 |
| Tinidazole | SFDA (Saudi Arabia), US FDA | 2 |
| Apixaban | US FDA | 1 |
| Edoxaban | US FDA | 1 |
| Felodipine | US FDA | 1 |
| Hydroxychloroquine | US FDA | 1 |
| Lamotrigine | US FDA | 1 |
| Linaclotide | US FDA | 1 |
| Linezolid | US FDA | 1 |
| Memantine | US FDA | 1 |
| Mitotane | US FDA | 1 |
| Olanzapine | US FDA | 1 |
| Quetiapine | US FDA | 1 |
| Rivaroxaban | US FDA | 1 |
| Rizatriptan | US FDA | 1 |
| Saxagliptin | US FDA | 1 |
| Secnidazole | US FDA | 1 |
| Tenofovir Disoproxil | US FDA | 1 |
| Ticagrelor | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Zhejiang Supor Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.